Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Immunohistochemical evaluation of ROCK activation in invasive breast cancer

Fig. 2

Competition of ROCKII S1366 phosphorylation immunohistochemical staining signal by peptide neutralization. Sample sections from one tumor of grade-3 invasive ductal carcinoma with axillary lymph node metastasis were stained with anti-pS1366 ROCKII antibody in the (a) absence or (b) presence of non-phosphorylated S1366 ROCKII peptide (0.3 μg/ml) or (c) phosphorylated S1366 ROCKII peptide (0.3 μg/ml). Scale bar, 20 μm

Back to article page